What's new in androgenetic alopecia: approvals, long-term safety data, cancer risk and treatment options for women.
Kendra Gail
KG
Bergstrom
D000505:Alopecia / Q000188:drug therapy* / Q000453:epidemiology; D001378:Azasteroids / Q000009:adverse effects; D017277:Drug Approval / Q000379:methods; D064420:Drug-Related Side Effects and Adverse Reactions / Q000139:chemically induced / Q000453:epidemiology; D000068538:Dutasteride; D005260:Female; D018120:Finasteride / Q000009:adverse effects; D006801:Humans; D008297:Male; D008914:Minoxidil / Q000009:adverse effects; D009369:Neoplasms / Q000139:chemically induced* / Q000453:epidemiology; D012307:Risk Factors; D013997:Time Factors
D001378:Azasteroids; D018120:Finasteride; D008914:Minoxidil; D000068538:Dutasteride